Clenbuterol ingestion causing prolonged tachycardia, hypokalemia, and hypophosphatemia with confirmation by quantitative levels

Journal of Toxicology - Clinical Toxicology

Volumn 39, Issue 4, 2001, Pages 339-344

  Hoffman, Robert J ^a   Hoffman, Robert S ^a   Freyberg, Christopher L ^b   Poppenga, Robert H ^c   Nelson, Lewis S ^a  

^a NEW YORK CITY POISON CONTROL CENTER   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CLENBUTEROL; ESMOLOL; METOPROLOL; POTASSIUM CHLORIDE; PROPRANOLOL;

ACUTE TOXICITY; ADULT; BIOAVAILABILITY; CASE REPORT; CONFERENCE PAPER; DRUG BLOOD LEVEL; DRUG HALF LIFE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HYPERGLYCEMIA; HYPOKALEMIA; HYPOMAGNESEMIA; HYPOPHOSPHATEMIA; INGESTION; LUNG DISEASE; QUANTITATIVE ASSAY; TACHYCARDIA; TOXICITY TESTING;

ADRENERGIC BETA-AGONISTS; ADULT; CLENBUTEROL; ELECTROCARDIOGRAPHY; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FOOD CONTAMINATION; GAS CHROMATOGRAPHY-MASS SPECTROMETRY; HUMANS; HYPOKALEMIA; HYPOPHOSPHATEMIA; MEAT; TACHYCARDIA, SINUS; TREMOR;

EID: 0034886790     PISSN: 07313810     EISSN: None     Source Type: Journal    
DOI: 10.1081/CLT-100105152     Document Type: Conference Paper

References (30)

1. Steady-state bioavailability and pharmacokinetics of ambroxol and clenbuterol administered alone and combined in a new oral formulation
2. Clenbuterol
3. Exosites: Their current status, and their relevance to the duration of long-acting beta 2-adrenoreceptor agonists
4. Human fat cell beta-adrenergic receptors: Beta agonist-dependent lipolytic responses and characterization of beta-adrenergic binding sites on human fat cell membranes with highly selective beta 1-antagonists
5. Clenbuterol residues in non-liver containing meat as a cause of collective food poisoning
6. Collective human food poisonings by clenbuterol residues in veal liver
7. Epidemiologic study of an outbreak of clenbuterol poisoning in catalonia, Spain
8. Clinical and pharmalogical profile in a clenbuterol epidemic poisoning of contaminated beef meat in Italy
9. The pharmacokinetics, metabolism, and tissue residues of beta-adrenergic agonists in livestock
10. Illegal use of beta-adrenergic agonists: European community
11. Illegal use of beta-adrenergic agonists in the United States
12. Acute poisoning with clenbuterol: A case report
13. Clenbuterol overdose in a young female
14. Drugs and sport. Research findings and limitations
15. Effect of clenbuterol on athletic performance
16. Compulsive weight lifting and anabolic drug abuse among women rape victims
17. Hypokalemia in an asthmatic child from abuse of albuterol metered dose inhaler
18. Hypokalemia after pediatric albuterol overdose: A case series
19. Theophylline toxicity and the beta-adrenergic system
20. Use of beta-blockade for acute theophylline poisoning
21. Enzyme immunoassay for clenbuterol, a beta 2-adrenergic stimulant
22. LC-MS-MS to detect and identify four beta-agonists and quantify clenbuterol in liver
23. The potential of restricted access medial columns as applied in coupled-column LC/LC/TSP/MS/MS for the high-speed determination of target compounds in serum. Application to the direct trace analysis of salbutamol and clenbuterol
24. Analysis of clenbuterol in human plasma using liquid chromatography/atmospheric-pressure chemical-ionization mass spectrometry
25. Gas chromatography-mass spectrometric analysis of clenbuterol from urine
26. Detection of anabolic steroids in head hair
27. Testing for natural and synthetic anabolic agents in human urine
28. Long-term detection of clenbuterol in human scalp hair by gas chromatography-high-resolution mass spectrometry
29. Quantitative determination of clenbuterol enatiomers in human plasma by high-performance liquid chromatography using the macroclyclic antibiotic chiral stationary phase teicoplanin
30. Doping control for beta-adrenergic compounds through hair analysis